Biopharma causes Cambrex bleed
Life sciences firm Cambrex has reported a $140.3m (€116.7m) loss in Q4 as opposed to a profit of $4.9m in Q4 last year, hit by lower long-term profitability projections for its Biopharma unit, as biotech companies seem to lose their appetite for...